(Reuters) -British equities slipped on Friday, pressured by healthcare shares, as investors woke up to U.S. President Donald Trump’s fresh levies on dozens of countries and demands to lower prescription drug prices.
The blue-chip FTSE 100 was down 0.7% as of 0915 GMT, on track to snap a six-week winning streak.
The domestically focused midcap FTSE 250 fell nearly 1% and headed for its second straight weekly decline.
Late on Thursday, Trump slapped steep tariffs on exports from dozens of trading partners including Canada, Brazil, India, Taiwan and Switzerland, pressing ahead with his plans to reorder the global economy.
British healthcare stocks dropped the most, down 2.3%, after Trump sent letters to the leaders of 17 major pharmaceutical companies on Thursday, including AstraZeneca and GSK, outlining how they should slash U.S. prescription drug prices.
AstraZeneca shed 3.4%, while GSK slipped 1.3%.
Industrial Support Services sector…
